![]() |
市場調査レポート
商品コード
1565601
AI支援放射線医学の世界市場:技術・用途・エンドユーザー・地域別の予測 (~2032年)Global AI-assisted Radiology Market Research Report Information by Technique, by Application, by End User, and by Region - Forecast till 2032 |
||||||
|
AI支援放射線医学の世界市場:技術・用途・エンドユーザー・地域別の予測 (~2032年) |
出版日: 2024年08月10日
発行: Market Research Future
ページ情報: 英文 131 Pages
納期: 即納可能
![]() |
世界のAI支援放射線医学の市場規模は、2023年の15億7,000万米ドル、2024年の20億3,000万米ドルから、予測期間中は32.96%のCAGRで推移し、2032年には271億8,000万米ドルの規模に成長すると予測されています。
AI支援放射線医学の市場は、AIを活用した医用画像診断のスタートアップの増加や参入事業者の戦略的取り組みによって牽引されています。市場成長はリソースとコストの制約によって抑制される可能性があるものの、世界的な医用画像処理向けAIへの資金の投入や投資が増加していることから、市場は有利な機会を得られると予測されています。
地域別展望
北米市場はさまざまな要因によって大幅な成長を示しています。放射線医学は、AIと機械学習の進歩によって大きく発展し、患者の転帰の改善、業務の合理化、診断精度の向上につながっています。
欧州のAI支援放射線医学市場は第2位の市場シェアを占めており、これは確立されたヘルスケアインフラと拡大するヘルスケア産業に起因しています。
アジア太平洋市場は、2024年から2032年にかけてもっとも急速な成長を遂げると予測されています。これは、医療支出の増加、オンライン小売チャネルの拡大、政府のイニシアティブおよび投資に起因しています。さらに、AI技術への投資も増加しています。
当レポートでは、世界のAI支援放射線医学の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global AI-assisted Radiology Market Research Report Information by Technique (X-rays, Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography (PET), and Others), by Application (Neurology, Mammography (Breast Cancer), Cardiovascular, Respiratory and Pulmonary, Orthopedics, and Others), by End User (Hospitals, Diagnostic Imaging Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2032
In 2023, the AI-assisted Radiology Market was estimated to be worth USD 1.57 billion. The AI-assisted Radiology Market industry is anticipated to experience a compound annual growth rate (CAGR) of 32.96% from USD 2.03 billion in 2024 to USD 27.18 billion by 2032 during the forecast period (2024-2032).
The AI-assisted Radiology Market is being driven by the increasing number of AI-powered medical imaging start-ups and the strategic initiatives of market players. Nevertheless, the global market's expansion is anticipated to be impeded by resource and cost constraints. However, it is anticipated that the market will generate lucrative opportunities as a result of the growing funding and investment in AI in medical imaging worldwide.
Market segment insights
The AI-assisted Radiology Market segmentation is defined by the technique used, which includes X-rays, magnetic resonance imaging, computed tomography, positron emission tomography (PET), and others.
The AI-assisted Radiology Market segmentation is categorized by application and includes neurology, mammography (breast cancer), cardiovascular, respiratory and pulmonary, orthopedics, and others.
Hospitals, diagnostic imaging centers, and other entities comprise the AI-assisted Radiology Market segmentation, which is based on end user.
Regional Perspectives
The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. Factors are propelling the substantial expansion of the North American AI-assisted Radiology market. Radiology has been revolutionized by advancements in artificial intelligence (AI) and machine learning, which have resulted in improved patient outcomes, streamlined operations, and increased diagnostic accuracy. This technical advancement addresses challenges such as the growing demand for effective healthcare delivery in the context of a radiology deficit and the increasing prevalence of chronic diseases.
The European AI-assisted Radiology market accounted for the second-largest market share, which is attributed to the well-established healthcare infrastructure and the expanding healthcare industry. Additionally, the Germany AI-assisted Radiology provider is considered to have the greatest market share, while the France AI-assisted Radiology providers are expected to have the fastest growing market in the European region.
The Asia-Pacific AI-assisted Radiology market is anticipated to experience the most rapid growth from 2024 to 2032. This is attributed to the increasing expenditure on healthcare, the expansion of online retail channels for healthcare products, and government initiatives and investments. Additionally, there is a rise in investments in AI technology.
Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), ContextVision AB (Sweden), GE Healthcare (US), FUJIFILM Corporation (Japan), Agfa-Gevaert Group (Belgium), ClariPi Inc (South Korea), Lunit Inc (South Korea), Enlitic Inc. (US), and NANO-X IMAGING LTD (Israel) are among the key companies in the AI-assisted Radiology market.